Core Laboratories (CLB) Receivables - Net (2022 - 2026)

Core Laboratories has reported Receivables - Net for 5 years, with the latest figure at $108.3 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 7.48% year-over-year to $108.3 million; the trailing twelve-month figure through Mar 2026 stood at $108.3 million (down 7.48% YoY), and the FY2025 full-year result was $113.5 million, up 1.58% from the prior year.
• Receivables - Net for Q1 2026 stood at $108.3 million, down from $113.5 million in the prior quarter.
• The five-year high for Receivables - Net was $117.6 million in Q3 2024, with the low at $104.1 million in Q3 2023.
• Historically, Receivables - Net has averaged $111.6 million across 5 years, with a median of $111.8 million in 2024.
• Annual changes were most pronounced in 2024 — Receivables - Net climbed 13.01% — and 2026, when it slipped 7.48%.
• Core Laboratories' Receivables - Net stood at $106.9 million in 2022, then climbed by 2.28% to $109.4 million in 2023, then advanced by 2.2% to $111.8 million in 2024, then climbed by 1.58% to $113.5 million in 2025, then decreased by 4.63% to $108.3 million in 2026.
• The last three Receivables - Net figures came in at $108.3 million (Q1 2026), $113.5 million (Q4 2025), and $110.3 million (Q3 2025), per Business Quant data.